Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Pathology”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01210404
What this trial is testing

Drug Interaction Study Of Filibuvir With Methadone Among Subjects On Chronic Methadone Maintenance

Who this might be right for
Chronic Hepatitis C
Pfizer 12
Large-scale testing (Phase 3)Looking for participantsNCT07296458
What this trial is testing

FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy

Who this might be right for
Primary Biliary Cholangitis (PBC)
Xijing Hospital of Digestive Diseases 132
Large-scale testing (Phase 3)Study completedNCT00516321
What this trial is testing

Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver Disease

Who this might be right for
Hepatitis C, Chronic
GlaxoSmithKline 687
Not applicableStudy completedNCT01442311
What this trial is testing

Directly Observed Hepatitis C Treatment in Methadone Clinics

Who this might be right for
Hepatitis CMedication Adherence
Albert Einstein College of Medicine 80
Early research (Phase 1)Study completedNCT00962871
What this trial is testing

Early Immunologic Response in Asian Patients With Chronic Hepatitis B, Treated With Pegasys (Peginterferon Alfa-2a (40KD)), Nucleoside Analogues, or Both

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 30
Post-approval studies (Phase 4)WithdrawnNCT00748904
What this trial is testing

Rifaximin Versus Lactulose in Renal Failure

Who this might be right for
Liver CirrhosisRenal Failure
Weill Medical College of Cornell University
Testing effectiveness (Phase 2)Study completedNCT06694038
What this trial is testing

Needle-Knife Fistulotomy Vs. Standard Cannulation Trial

Who this might be right for
Biliary Obstruction Due to Common Bile Duct StoneMalignant Bile Duct Obstruction
Thomas Jefferson University 186
Post-approval studies (Phase 4)Study completedNCT00487747
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis B.

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 18
Testing effectiveness (Phase 2)Study completedNCT00722358
What this trial is testing

A Multiple Ascending Dose Study of BMS-650032 in HCV Infected Subjects

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 15
Testing effectiveness (Phase 2)Study completedNCT00083785
What this trial is testing

Study of the Litx™ System Combined With Chemotherapy in Patients With Colorectal Liver Metastases

Who this might be right for
Liver MetastasisColorectal NeoplasmsLiver Neoplasms+1 more
Light Sciences LLC 25
Not applicableStudy completedNCT01509391
What this trial is testing

Keyhole Limpet Hemocyanin in Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis CLiver Cirrhosis
Medical University of Graz 14
Not applicableStudy completedNCT06688149
What this trial is testing

NASH Patient's Itinerary: Comparison of Strategies for Screening, Referring and Management of Diabetic Patients

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 536
Not applicableStudy completedNCT04953143
What this trial is testing

LiverPAL: A Pilot Study of Inpatient Palliative Care for Patients With Advanced Liver Disease

Who this might be right for
Cirrhosis, Liver
Massachusetts General Hospital 25
Not applicableTemporarily pausedNCT04199910
What this trial is testing

4beta-hydroxycholesterol in Cirrhosis

Who this might be right for
Cirrhosis, Liver
University of Oulu 120
Testing effectiveness (Phase 2)Study completedNCT01762748
What this trial is testing

Effect of Saccharomyces Boulardii in Patients in the Waiting List for Liver Transplant

Who this might be right for
Liver Cirrhosis
Federal University of Minas Gerais 18
Not applicableStudy completedNCT03534843
What this trial is testing

A Comparison Between Child-Pugh and Albumin-Bilirubin Scores

Who this might be right for
Rupture, SpontaneousRupture LiverHepatocellular Carcinoma+1 more
Huazhong University of Science and Technology 230
Testing effectiveness (Phase 2)Looking for participantsNCT06920043
What this trial is testing

Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

Who this might be right for
Metabolic Dysfunction-Associated SteatohepatitisNon-alcoholic Fatty Liver Disease
GlaxoSmithKline 42
Testing effectiveness (Phase 2)Looking for participantsNCT07763015
What this trial is testing

Study of Resmetirom in Children and Adolescents With MASH

Who this might be right for
MASHMASH - Metabolic Dysfunction-Associated Steatohepatitis
Madrigal Pharmaceuticals, Inc. 61
Not applicableStudy completedNCT03262025
What this trial is testing

Primary Cecal Pathologies Presenting as Acute Abdomen

Who this might be right for
Acute AbdomenEmergency SurgeryLaparotomy+3 more
Jawaharlal Nehru Medical College 43
Early research (Phase 1)Not Yet RecruitingNCT07787650
What this trial is testing

S-606001 as Monotherapy in Participants With Late-onset Pompe Disease (LOPD)

Who this might be right for
Pompe Disease
Shionogi 15
Next Page